Home › Funds › ELKHORN PARTNERS LIMITED PARTNERSHIP › CME

ELKHORN PARTNERS LIMITED PARTNERSHIP position in CME

CME GROUP INC · Financials

ELKHORN PARTNERS LIMITED PARTNERSHIP reported holding 3,000 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$786K, representing 0.68% of its reported portfolio and ranking #11 among its reported holdings. ELKHORN PARTNERS LIMITED PARTNERSHIP has disclosed CME holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.00K sh
Reported value held$785.94K
Portfolio Weight0.68%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ELKHORN PARTNERS LIMITED PARTNERSHIP's CME position evolved

ELKHORN PARTNERS LIMITED PARTNERSHIP first disclosed a stake in CME in Q3 2023 at 3,945 shares (US$790K). The position peaked in Q2 2024 at 5,200 shares, worth US$1.0M. Across 9 filings, ELKHORN PARTNERS LIMITED PARTNERSHIP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,000 shares valued at US$786K — a reduction of -1,500 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2024 (shares rose 5% over the following quarter), a 58% trim in Q4 2024 (shares rose 14% over the following quarter), a 33% trim in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.94K $790.00K New
Q4 2023 4.35K $916.00K Add
Q1 2024 4.50K $969.00K Add
Q2 2024 5.20K $1.02M Add
Q3 2024 2.60K $574.00K Reduce
Q4 2024 1.10K $255.00K Reduce
Q4 2025 100 $27.31K New
Q2 2026 4.50K $993.74K New
Q3 2026 3.00K $785.94K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has ELKHORN PARTNERS LIMITED PARTNERSHIP held CME?

ELKHORN PARTNERS LIMITED PARTNERSHIP has disclosed CME holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is ELKHORN PARTNERS LIMITED PARTNERSHIP's current position in CME?

As of Q3 2026, ELKHORN PARTNERS LIMITED PARTNERSHIP holds 3.00K shares of CME (CME GROUP INC), valued at $785.94K, representing 0.68% of its reported portfolio and ranking #11.

Has ELKHORN PARTNERS LIMITED PARTNERSHIP been buying or selling CME?

In the latest 13F filing (Q3 2026), ELKHORN PARTNERS LIMITED PARTNERSHIP reduced its position in CME. The position peaked in Q2 2024 at 5.20K shares.

Which other funds hold CME?

Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.